Clinical course of liver cirrhosis and liver cirrhosis complications

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00013117

Enrollment

500

Registered

2017-11-28

Start date

2013-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K74.6 K70.3

Interventions

Group 1: In patients with compensated and decompensated cirrhosis of the liver, data such as patient characteristics, clinical risk characteristics, laboratory chemical results and the results of endo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with liver cirrhosis Age > 18 yrs. In- or outpatient treatment at the University Hospital Mainz Written informed consent

Exclusion criteria

Exclusion criteria: Not able to provide written informed consent

Design outcomes

Primary

Measure	Time frame
The aim of this clinical study is to gain a better understanding of the course of liver cirrhosis, the individual predisposition for the development of certain liver cirrhosis complications and the effect of therapeutic measures and interventions.	—

Secondary

Measure	Time frame
Influence of liver cirrhosis and liver cirrhosis complications on patients' and patient carer's quality of life (CQLD, WHOQOL-BREF, ZBI)	—

Countries

Germany

Contacts

Public ContactMarc Nguyen-Tat

I. Medizinische Klinik und PoliklinikCirrhose Centrum Mainz (CCM)

marc.nguyen-tat@uni-mainz.de+49 6131 17-5711

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026